Breaking News
Get 40% Off 0
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought it Read More
Close

Seoulin Bioscience Co Ltd (038070)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8,600 -150    -1.71%
13:31:39 - Delayed Data. Currency in KRW ( Disclaimer )
Type:  Equity
Market:  South Korea
ISIN:  KR7038070009 
  • Volume: 15,154
  • Bid/Ask: 8,590 / 8,600
  • Day's Range: 8,600 - 8,760
Seoulin Bioscience 8,600 -150 -1.71%

038070 Balance Sheet

 
Featured here, the Balance Sheet for Seoulin Bioscience Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 62572.87 72954.68 94135.17 93575.77
Cash and Short Term Investments 30973.94 35414.2 56649.89 54678.92
Cash - - - -
Cash & Equivalents 13745.92 14601.83 13719.6 9016.33
Short Term Investments 17136.83 20722.06 42930.29 45662.59
Total Receivables, Net 7731.67 14293.84 7665.61 10945.24
Accounts Receivables - Trade, Net 6583.89 12985.71 7278.63 9985.49
Total Inventory 22030.88 21785.33 27258.26 23307.94
Prepaid Expenses 23.55 53.74 127.93 30.06
Other Current Assets, Total 1812.82 1407.58 2433.48 4613.61
Total Assets 103497.21 114099.91 138408.85 137257.96
Property/Plant/Equipment, Total - Net 18648.93 18913.98 19203.01 19046.41
Property/Plant/Equipment, Total - Gross 18648.93 18913.98 19203.01 19046.41
Accumulated Depreciation, Total - - - -
Goodwill, Net 526.49 526.49 526.49 526.49
Intangibles, Net 422.79 425.08 215.65 234.4
Long Term Investments 17538.39 17512.11 20638.95 20592.43
Note Receivable - Long Term 1134.63 1291.79 370.52 959.76
Other Long Term Assets, Total 1331.16 1334.85 1564.21 1404.51
Other Assets, Total 35809.8 32160.5 67098.26 64516.86
Total Current Liabilities 17564.91 28030.19 48460.79 47914
Accounts Payable 5402.09 11428.3 10822.11 10280.4
Payable/Accrued - - - -
Accrued Expenses 1216.03 387.97 301.26 252.12
Notes Payable/Short Term Debt 3081.44 6120.05 19904.07 19232.53
Current Port. of LT Debt/Capital Leases 274.96 271.44 267.99 237.57
Other Current liabilities, Total 7590.39 9822.42 17165.36 17911.38
Total Liabilities 18539.96 28860.67 49149.3 48428.16
Total Long Term Debt 252.36 322.89 392.22 362.57
Long Term Debt 98.6 98.6 98.6 98.6
Capital Lease Obligations 153.76 224.29 293.62 263.97
Deferred Income Tax - - - -
Minority Interest 2165.29 2176.58 4181.86 4305.81
Other Liabilities, Total -4524.03 -7789.04 -23789.64 -23386.76
Total Equity 84957.25 85239.24 89259.55 88829.8
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 4450.34 4350.34 4350.34 4350.34
Additional Paid-In Capital 18519.35 18519.35 18490.16 18490.16
Retained Earnings (Accumulated Deficit) 66806.76 67177.46 69192.48 68638.78
Treasury Stock - Common -3403.56 -3403.56 -3403.56 -3403.56
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -1415.63 -1404.34 630.14 754.08
Total Liabilities & Shareholders' Equity 103497.21 114099.91 138408.85 137257.96
Total Common Shares Outstanding 8.55 8.56 8.56 8.56
Total Preferred Shares Outstanding - - - -
* In Millions of KRW (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

038070 Comments

Write your thoughts about Seoulin Bioscience Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email